Acceptance of recommendations by inpatient pharmacy case managers: Unintended consequences of hospitalist and specialist care

Pharmacotherapy

Volumn 33, Issue 1, 2013, Pages 11-21

  Anderegg, Sammuel V ^a   Demik, David E ^b   Carter, Barry L ^b,c,e   Dawson, Jeffrey D ^b   Farris, Karen ^d   Shelsky, Constance ^b   Kaboli, Peter ^c,e  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse drug reactions; Hospital readmissions; Pharmacy services

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY CARE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDICATION; HEALTH CARE; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL PHYSICIAN; HOSPITAL READMISSION; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MEDICATION ERROR; PATIENT COUNSELING; PATIENT MONITORING; PHARMACIST; PHARMACY; PHARMACY BENEFIT MANAGER; PHYSICIAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE; UNITED STATES;

CASE MANAGEMENT; COMMUNITY PHARMACY SERVICES; GUIDELINE ADHERENCE; HOSPITALISTS; HUMANS; PATIENT DISCHARGE; PHARMACISTS; PROSPECTIVE STUDIES; SPECIALIZATION; TERTIARY HEALTHCARE;

EID: 84875458953     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1164     Document Type: Article

References (36)

1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28.
2. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166:955-64.
3. Jiang HJ, Wier LM. All-cause hospital readmissions among non-elderly Medicaid patients, 2007. Agency for Healthcare Research and Quality, 2010. Available from http://www.hcupus.ahrq.gov/reports/statbriefs/sb89.pdf. Accessed February 13, 2012.
4. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.
5. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy 2007;27:481-93.
6. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999;19:556-64.
7. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 2001;21:129-41.
8. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002;22:134-47.
9. Kosecoff J, Kahn KL, Rogers WH, et al. Prospective payment system and impairment at discharge. The 'quicker-and-sicker' story revisited. JAMA 1990;264:1980-3.
10. Lizer MH, Brackbill ML. Medication history reconciliation by pharmacists in an inpatient behavioral health unit. Am J Health Syst Pharm 2007;64:1087-91.
11. Varkey P, Cunningham J, O'Meara J, Bonacci R, Desai N, Sheeler R. Multidisciplinary approach to inpatient medication reconciliation in an academic setting. Am J Health Syst Pharm 2007;64:850-4.
12. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
13. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002;59:2089-92.
14. Bjornson DC, Hiner WO Jr, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
15. Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988;45: 2329-40.
16. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002;54:657-64.
17. Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to patients after hospitalization. Am J Med 2001;111:26S-30S.
18. Makowsky MJ, Koshman SL, Midodzi WK, Tsuyuki RT. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]. Med Care 2009;47:642-50.
19. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010;48:923-33.
20. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
21. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens 2008;10: 260-71.
22. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci 2008;30: 128-35.
23. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565-71.
24. Lisby M, Thomsen A, Nielsen LP, et al. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine. Basic Clin Pharmacol Toxicol 2010;106:422-7.
25. Carter BL, Farris KB, Abramowitz PW, et al. The Iowa continuity of care study: background and methods. Am J Health Syst Pharm 2008;65:1631-42.
26. Hoth AB, Carter BL, Ness J, et al. Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy 2007;27:639-46.
27. McDonough R, Doucette W. A conceptual framework for collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc 2001;8:55-69.
28. Zillich AJ, Doucette WR, Carter BL, Kreiter CD. Development and initial validation of an instrument to measure physicianpharmacist collaboration from the physician perspective. Value Health 2005;8:59-66.
29. Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004;38:764-70.
30. Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc 2006;46:453-8.
31. Prosser H, Walley T. New drug prescribing by hospital doctors: the nature and meaning of knowledge. Soc Sci Med 2006;62:1565-78.
32. Lee AJ, Boro MS, Knapp KK, Meier JL, Korman NE. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm 2002;59:2070-7.
33. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
34. May FE, Stewart RB, Cluff LE. Drug interactions and multiple drug administration. Clin Pharmacol Ther 1977;22:322-8.
35. Curry LA, Spatz E, Cherlin E, et al. What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? A qualitative study. Ann Intern Med 2011;154: 384-90.
36. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist- initiated interventions. Arch Intern Med 1999;159: 2306-9.